+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Probiotics for Prevention and Treatment of Clostridium difficile Infection



Probiotics for Prevention and Treatment of Clostridium difficile Infection



Advances in Experimental Medicine and Biology 1050: 161-176



Probiotics have been claimed as a valuable tool to restore the balance in the intestinal microbiota following a dysbiosis caused by, among other factors, antibiotic therapy. This perturbed environment could favor the overgrowth of Clostridium difficile and, in fact, the occurrence of C. difficile-associated infections (CDI) is being increasing in recent years. In spite of the high number of probiotics able to in vitro inhibit the growth and/or toxicity of this pathogen, its application for treatment or prevention of CDI is still scarce since there are not enough well-defined clinical studies supporting efficacy. Only a few strains, such as Lactobacillus rhamnosus GG and Saccharomyces boulardii have been studied in more extent. The increasing knowledge about the probiotic mechanisms of action against C. difficile, some of them reviewed here, makes promising the application of these live biotherapeutic agents against CDI. Nevertheless, more effort must be paid to standardize the clinical studied conducted to evaluate probiotic products, in combination with antibiotics, in order to select the best candidate for C. difficile infections.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065436228

Download citation: RISBibTeXText

PMID: 29383669

DOI: 10.1007/978-3-319-72799-8_10


Related references

Use of probiotics in prevention and treatment of patients with Clostridium difficile infection. Best Practice and Research. Clinical Gastroenterology 30(1): 111-118, 2016

Probiotics for prevention of Clostridium difficile infection. Current Opinion in Gastroenterology 34(1): 3, 2018

Probiotics and prevention of Clostridium difficile infection. Anaerobe 45: 114-119, 2017

Prevention of Clostridium difficile Infection With Probiotics. Clinical Infectious Diseases 60(Suppl. 2): S122-S128, 2015

Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therapeutic Advances in Gastroenterology 4(3): 185-197, 2011

Is primary prevention of Clostridium difficile infection possible with specific probiotics?. International Journal of Infectious Diseases 16(11): E786-E792, 2012

Probiotics for Prevention of Clostridium difficile Infection in Hospitalized Patients: Is the Jury Still Out?. Gastroenterology 152(8): 1817-1819, 2017

Risks of Saccharomyces boulardii-Containing Probiotics for the Prevention of Clostridium difficile Infection in the Elderly. Gastroenterology 153(5): 1450-1451, 2017

Current status of probiotics usage for the prevention of a first episode of Clostridium difficile infection. Revue Medicale Suisse 14(623): 1834-1837, 2018

Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection. PharmacoTherapy 35(11): 1016-1025, 2015

Probiotics for the prevention and treatment of Clostridium difficile in older patients. Age and Ageing 41(6): 706-711, 2012

The role of probiotics in the prevention and treatment of antibiotic-associated diarrhea and Clostridium difficile colitis. Gastroenterology Clinics of North America 41(4): 763-779, 2012

Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis. Open Medicine 7(2): E56-E67, 2013

Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients systematic review and meta-analysis. 2013

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. American Journal of Gastroenterology 101(4): 812-822, 2006